Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel paclitaxel analogues under evaluation at Bristol-Myers

July 21, 1999

Abgenix files IND for ABX-EGF

July 21, 1999

Hodgkin's lymphoma cell discovered by international team

July 20, 1999

Preclinical activity, current status of potent P-glycoprotein inhibitor discussed at congress

July 19, 1999

New cytoprotective compound that acts by inhibiting PARP activity developed at N-Gene

July 19, 1999

PDT with Photofrin cleared in Canada for certain forms of lung cancer

July 19, 1999

Triazine-based inhibitors of angiogenesis designed by Abbott researchers

July 19, 1999

MPBX's enhancement of doxorubicin activity examined in P388 leukemia

July 19, 1999

Interim data released for NeoRx's STR product in multiple myeloma

July 19, 1999

First clinically evaluated ribozyme-based product proves safe in volunteers and patients

July 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...